<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30111869</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses.</ArticleTitle><Pagination><StartPage>12184</StartPage><MedlinePgn>12184</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-30631-2</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) infection can induce encephalitis, which causes death or long-term neurological sequelae, especially in young children. Using a murine infection model, we searched for anti-EV-A71 agents, because effective therapies are not available to control fatal infection. In EV-A71-infected mice, treatment with the hematopoietic growth factor, Fms-like tyrosine-kinase 3 ligand (Flt3 ligand) before infection reduced the lethality and tissue viral loads. Flt3 ligand failed to enhance the production of type I interferons. Instead, Flt3 ligand boosted the numbers of dendritic cells and, particularly lymphocytes in infected organs with an expansion of spleen B cells, and resulted in an increased titer of virus-specific antibody with neutralizing activity in the serum. The protective effect of Flt3 ligand was abolished in B cell-deficient mice. Our findings revealed that Flt3 ligand administration promotes resistance to EV-A71 infection with enhanced B cell response in a mechanism rarely reported before.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yu-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li-Chiu</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chien-Kuo</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shun-Hua</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-4585-9279</Identifier><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. shunhua@mail.ncku.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. shunhua@mail.ncku.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C084881">flt3 ligand protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C497970">FLT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D051941">fms-Like Tyrosine Kinase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051941" MajorTopicYN="N">fms-Like Tyrosine Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30111869</ArticleId><ArticleId IdType="pmc">PMC6093920</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-30631-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-30631-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang CC, et al. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 1999;341:936&#x2013;942. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 2007;356:1226&#x2013;1234. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol. 2008;7:868&#x2013;869. doi: 10.1016/S1474-4422(08)70207-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70207-2</ArticleId><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O, Arnheiter H, Gresser I, Lindenmann J. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 1981;154:199&#x2013;203. doi: 10.1084/jem.154.1.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.154.1.199</ArticleId><ArticleId IdType="pmc">PMC2186399</ArticleId><ArticleId IdType="pubmed">6166723</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollstedt S, et al. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J. Exp. Med. 2003;197:575&#x2013;584. doi: 10.1084/jem.20021900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021900</ArticleId><ArticleId IdType="pmc">PMC2193820</ArticleId><ArticleId IdType="pubmed">12615899</ArticleId></ArticleIdList></Reference><Reference><Citation>Remot A, et al. Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice. Eur. J. Immunol. 2016;46:874&#x2013;884. doi: 10.1002/eji.201545929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545929</ArticleId><ArticleId IdType="pubmed">26681580</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidman CL, Unanue ER. Development of B lymphocytes. I. Cell populations and a critical event during ontogeny. J. Immunol. 1975;114:1730&#x2013;1735.</Citation><ArticleIdList><ArticleId IdType="pubmed">1092758</ArticleId></ArticleIdList></Reference><Reference><Citation>Spear PG, Wang AL, Rutishauser U, Edelman GM. Characterization of splenic lymphoid cells in fetal and newborn mice. J. Exp. Med. 1973;138:557&#x2013;573. doi: 10.1084/jem.138.3.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.138.3.557</ArticleId><ArticleId IdType="pmc">PMC2139421</ArticleId><ArticleId IdType="pubmed">4580464</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263&#x2013;3269. doi: 10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LC, et al. Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation. J. Virol. 2015;89:7028&#x2013;7037. doi: 10.1128/JVI.00205-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00205-15</ArticleId><ArticleId IdType="pmc">PMC4473548</ArticleId><ArticleId IdType="pubmed">25926657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, et al. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 2009;83:6477&#x2013;6483. doi: 10.1128/JVI.00434-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00434-09</ArticleId><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbone FR, Heath WR. The role of dendritic cell subsets in immunity to viruses. Curr. Opin. Immunol. 2003;15:416&#x2013;420. doi: 10.1016/S0952-7915(03)00074-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-7915(03)00074-8</ArticleId><ArticleId IdType="pubmed">12900273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambotin M, Raghuraman S, Stoll-Keller F, Baumert TF, Barth H. A look behind closed doors: interaction of persistent viruses with dendritic cells. Nat. Rev. Microbiol. 2010;8:350&#x2013;360. doi: 10.1038/nrmicro2332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2332</ArticleId><ArticleId IdType="pmc">PMC2988821</ArticleId><ArticleId IdType="pubmed">20372157</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008;8:594&#x2013;606. doi: 10.1038/nri2358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2358</ArticleId><ArticleId IdType="pubmed">18641647</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit JJ, Rudd BD, Lukacs NW. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 2006;203:1153&#x2013;1159. doi: 10.1084/jem.20052359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20052359</ArticleId><ArticleId IdType="pmc">PMC2121199</ArticleId><ArticleId IdType="pubmed">16682497</ArticleId></ArticleIdList></Reference><Reference><Citation>Villadangos JA. &amp; Schnorrer, P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 2007;7:543&#x2013;555. doi: 10.1038/nri2103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2103</ArticleId><ArticleId IdType="pubmed">17589544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauterbach H, Zuniga EI, Truong P, Oldstone MB, McGavern DB. Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. J. Exp. Med. 2006;203:1963&#x2013;1975. doi: 10.1084/jem.20060039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20060039</ArticleId><ArticleId IdType="pmc">PMC2118382</ArticleId><ArticleId IdType="pubmed">16847068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassim SH, Rajasagi NK, Zhao X, Chervenak R, Jennings SR. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J. Virol. 2006;80:3985&#x2013;3993. doi: 10.1128/JVI.80.8.3985-3993.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.8.3985-3993.2006</ArticleId><ArticleId IdType="pmc">PMC1440460</ArticleId><ArticleId IdType="pubmed">16571815</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadaglio G, Sun CM, Lo-Man R, Siegrist CA, Leclerc C. Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells. J. Immunol. 2002;168:2219&#x2013;2224. doi: 10.4049/jimmunol.168.5.2219.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.5.2219</ArticleId><ArticleId IdType="pubmed">11859108</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolence JJ, Gwin KA, Shapiro MB, Medina KL. Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors. Exp. Hematol. 2014;42:380&#x2013;393 e383. doi: 10.1016/j.exphem.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC4089881</ArticleId><ArticleId IdType="pubmed">24444745</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasel K, et al. Hematologic effects of flt3 ligand in vivo in mice. Blood. 1996;88:2004&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">8822919</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraskovsky E, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 1996;184:1953&#x2013;1962. doi: 10.1084/jem.184.5.1953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.5.1953</ArticleId><ArticleId IdType="pmc">PMC2192888</ArticleId><ArticleId IdType="pubmed">8920882</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit JJ, et al. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS One. 2008;3:e1720. doi: 10.1371/journal.pone.0001720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001720</ArticleId><ArticleId IdType="pmc">PMC2249704</ArticleId><ArticleId IdType="pubmed">18320041</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JR, Thackray AM, Bujdoso R. Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells. Immunology. 2001;102:352&#x2013;358. doi: 10.1046/j.1365-2567.2001.01180.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.2001.01180.x</ArticleId><ArticleId IdType="pmc">PMC1783181</ArticleId><ArticleId IdType="pubmed">11298835</ArticleId></ArticleIdList></Reference><Reference><Citation>Greter M, et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005;11:328&#x2013;334. doi: 10.1038/nm1197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1197</ArticleId><ArticleId IdType="pubmed">15735653</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 2013;31:563&#x2013;604. doi: 10.1146/annurev-immunol-020711-074950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-074950</ArticleId><ArticleId IdType="pmc">PMC3853342</ArticleId><ArticleId IdType="pubmed">23516985</ArticleId></ArticleIdList></Reference><Reference><Citation>Anandasabapathy N, et al. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 2011;208:1695&#x2013;1705. doi: 10.1084/jem.20102657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20102657</ArticleId><ArticleId IdType="pmc">PMC3149213</ArticleId><ArticleId IdType="pubmed">21788405</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao HB, et al. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns. J. Virol. 2014;88:11658&#x2013;11670. doi: 10.1128/JVI.00867-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00867-14</ArticleId><ArticleId IdType="pmc">PMC4178751</ArticleId><ArticleId IdType="pubmed">25078697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LC, et al. CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads. Clin. Dev. Immunol. 2012;2012:580696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3486008</ArticleId><ArticleId IdType="pubmed">23133489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr. Res. 2006;60:466&#x2013;471. doi: 10.1203/01.pdr.0000238247.86041.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.pdr.0000238247.86041.19</ArticleId><ArticleId IdType="pmc">PMC7086547</ArticleId><ArticleId IdType="pubmed">16940249</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 2003;188:564&#x2013;570. doi: 10.1086/376998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, et al. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta. Paediatr. 2002;91:632&#x2013;635. doi: 10.1111/j.1651-2227.2002.tb03292.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2002.tb03292.x</ArticleId><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 2008;198:1002&#x2013;1006. doi: 10.1086/591462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591462</ArticleId><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan MA, et al. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology. 2003;60:1651&#x2013;1656. doi: 10.1212/01.WNL.0000066810.62490.FF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000066810.62490.FF</ArticleId><ArticleId IdType="pubmed">12771257</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 2001;32:236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen FH, Shen TJ, Chang TM, Su IJ, Chen SH. Early dexamethasone treatment exacerbates enterovirus 71 infection in mice. Virology. 2014;464&#x2013;465:218&#x2013;227. doi: 10.1016/j.virol.2014.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.07.021</ArticleId><ArticleId IdType="pubmed">25104614</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J, McPherson CM, Stambrook PJ. Flt-3 ligand: a potent dendritic cell stimulator and novel antitumor agent. Cancer Biol. Ther. 2002;1:486&#x2013;489. doi: 10.4161/cbt.1.5.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cbt.1.5.161</ArticleId><ArticleId IdType="pubmed">12496473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwissa M, et al. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J. Exp. Med. 2007;204:2733&#x2013;2746. doi: 10.1084/jem.20071211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071211</ArticleId><ArticleId IdType="pmc">PMC2118478</ArticleId><ArticleId IdType="pubmed">17954572</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZH, et al. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 2008;197:854&#x2013;857. doi: 10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 2004;78:7916&#x2013;7924. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen FH, et al. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues. J. Gen. Virol. 2013;94:1019&#x2013;1027. doi: 10.1099/vir.0.046383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.046383-0</ArticleId><ArticleId IdType="pubmed">23288420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>